EEHV

Oscar-Award Winning ‘My Octopus Teacher’ Nature Documentarian James Reed to Make Docuseries About De-Extinction Company Colossal, to be Produced by Underdog Films and Teton Ridge Entertainment

Retrieved on: 
水曜日, 2月 21, 2024
Entertainment, Health, Environment, Film & Motion Pictures, Genetics, Environmental Issues, Biotechnology, Engineering, DNA, Netflix, Television, Multimedia, Intelligence, EEHV, My Octopus Teacher, Drive, Animal, Nature, Monster, WME, Colossal Biosciences, De-extinction, Genetic engineering, Elephant, Best, History, Showrunner, Jillian, Science, Reed

Reed and producing partner Matt Houghton will executive produce for Underdog, along with Jillian Share for Teton Ridge Entertainment.

Key Points: 
  • Reed and producing partner Matt Houghton will executive produce for Underdog, along with Jillian Share for Teton Ridge Entertainment.
  • Specialist observational film-maker Sophie Todd (Formula 1 - Drive To Survive) has joined as Showrunner.
  • I feel very privileged that we have the opportunity to bring this story to the world,” said James Reed.
  • Said Share of the docuseries, “Colossal’s trailblazing mission to de-extinct animals embodies the pioneering spirit that Teton Ridge Entertainment aims to celebrate.

Toledo Zoo's Elephant Herd Grows with Arrival of Newborn Calf

Retrieved on: 
月曜日, 3月 4, 2024
SSP, Zoo, Calf, Kroger, Social media, Love, Threatened species, Birmingham Zoo, Intelligence, EEHV, Animal, Elephant, Pregnancy, Toledo Zoo & Aquarium, PR, Health, Zoo Aquarium de Madrid, Mammal, Family, Indianapolis Zoo, Amazon, Male, Plasma, USDA, IUCN, Tembo

TOLEDO, Ohio, March 4, 2024 /PRNewswire/ -- The Toledo Zoo is thrilled to announce the birth of a healthy baby elephant, born to African elephant, Renee.

Key Points: 
  • TOLEDO, Ohio, March 4, 2024 /PRNewswire/ -- The Toledo Zoo is thrilled to announce the birth of a healthy baby elephant, born to African elephant, Renee.
  • "The birth of this precious baby elephant is such a momentous event," said Jeff Sailer, CEO of the Toledo Zoo.
  • "It took months of coordination working with our partners in the field," said Michael Frushour, curator of mammals at the Toledo Zoo.
  • In addition to Renee and the newborn calf, the Zoo is also home to two other elephants, Twiggy and Ajani.

Colossal Biosciences and Save the Elephants Debut First-of-its-Kind Project to Utilize Drones and Machine Learning for Elephant Conservation

Retrieved on: 
木曜日, 11月 9, 2023
Hardware, Sustainability, Technology, Philanthropy, Other Natural Resources, Environment, Environmental Issues, Environmental Health, Artificial Intelligence, Drones, Natural Resources, Foundation, Software, Internet, Mobile, Wireless, Vertebrate Genomes Project, Save the Elephants, Science and technology in Asia, Crime, Intelligence, Biodiversity, VGP, Behavior, Animal husbandry, Carbon, Genetic code, EEHV, Research, Observation, Multimedia, DNA, Death, Elephant, Growth, Genome, Machine learning, Social behavior, Reproductive technology, Assisted migration, Colossal Biosciences, Animal, Credit, Ecology, Algorithm, AI, Map, Hunting, Management, Colossal, Arctic

(Credit: Colossal Biosciences)

Key Points: 
  • (Credit: Colossal Biosciences)
    In this collaboration, Save the Elephants will deploy a small fleet of drones equipped with high resolution and infrared cameras to capture elephant behavioral data.
  • “The technological sophistication of modern drones, combined with appropriate analysis including the use of Machine Learning and AI expertise, will reveal many novel insights into elephant behavior and ecology.
  • And the better we understand elephants, the more we can help to secure a future for these iconic giants,” said Fritz Vollrath of Save the Elephants.
  • Colossal is working closely with the Save the Elephants team, including CEO Frank Pope and Colossal Scientific Advisor and Save the Elephants Chairman, Fritz Vollrath.

Colossal Biosciences Named to TIME’s List of the TIME100 Most Influential Companies

Retrieved on: 
水曜日, 6月 21, 2023
Science, Other Science, Biotechnology, Sustainability, Environment, Health, Climate Change, Genetics, EEHV, Colossal Biosciences, Woolly mammoth, Thylacine, TIME, Multimedia, Elephant, Hunting, Colossal

Colossal Biosciences ("Colossal"), the world’s first de-extinction company, has been named to the third-annual TIME100 Most Influential Companies list, which recognizes 100 companies making an extraordinary impact around the world.

Key Points: 
  • Colossal Biosciences ("Colossal"), the world’s first de-extinction company, has been named to the third-annual TIME100 Most Influential Companies list, which recognizes 100 companies making an extraordinary impact around the world.
  • View the full release here: https://www.businesswire.com/news/home/20230621594972/en/
    “Colossal is honored to be recognized as one of TIME100’s Most Influential Companies.
  • Since 2021, Colossal has raised $225M in total funding, with its most recent oversubscribed $150M Series B financing in 2023.
  • To assemble the list, TIME solicited nominations from its global network of contributors and correspondents as well as from outside experts.

Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo

Retrieved on: 
火曜日, 1月 31, 2023
Hardware, Health Technology, Environmental, Social and Governance (ESG), Technology, Stem Cells, Professional Services, Environment, Environmental Issues, Genetics, Agriculture, Natural Resources, Biotechnology, Science, Software, Research, Health, Gene editing, Synthetic biology, Protein engineering, Colossal Biosciences, United States Air Force Scientific Advisory Board, Save the Elephants, Partnership, Animoca Brands, Multimedia, IUCN Red List, Genome, International Elephant Foundation, Gametogenesis, Cornell Lab of Ornithology, Elephant, Computational biology, George Church, Series, Ecosystem, University, Jim Breyer, Reading, Baylor College of Medicine, Genomics, Mammoth, DNA, Life, Classroom, Bird, Hope, Biology, Genetic engineering, Permafrost, Carbon, Embryology, Dodo, B cell, Duane, Laboratory, Forrest Galante, EEHV, USIT, CRISPR, Biofuel, Biodiversity, Woolly mammoth, University of Alaska Fairbanks, Management, Hunting, Antibiotics, Thylacine, Colossal

View the full release here: https://www.businesswire.com/news/home/20230131005411/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230131005411/en/
    Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisory Board Member) and Ben Lamm (Colossal Co-Founder and CEO).
  • Since launching in September 2021, Colossal has raised $225M in total funding.
  • Colossal is on a mission to reverse these staggering statistics through genetic rescue techniques and its de-extinction toolkit.
  • Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth.

Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction

Retrieved on: 
水曜日, 10月 5, 2022
Technology, Biotechnology, Health, Environmental Issues, Professional Services, Environmental, Social and Governance (ESG), Other Philanthropy, Philanthropy, Other Science, Environment, Other Technology, Research, Genetics, Science, Genetic code, Houston Zoo, Disease, RNA transfection, Life, Elephas, EEHV, Virology, Genetic engineering, Research, List of life sciences, Baylor University, Mammoth, Multimedia, VGP, Partnership, Technology, Biodiversity, Department, Health, African bush elephant, CRISPR, Genetics, Elephant, New product development, Vertebrate Genomes Project, Death, Baylor College of Medicine, Hunting, African elephant, Barn, Colossal

Colossal Biosciences, a breakthrough genetic engineering and de-extinction company, accelerates efforts to end elephant extinction on Earth.

Key Points: 
  • Colossal Biosciences, a breakthrough genetic engineering and de-extinction company, accelerates efforts to end elephant extinction on Earth.
  • Colossal will lead the development of novel treatments and a vaccine to prevent the deadly disease and protect as many elephants as possible - both in zoos and in their natural habitats.
  • Colossal and Dr. Lings lab will accelerate milestones in three phases, including the development and rollout of a protein subunit vaccine, the development of an mRNA vaccine, and the development of a monoclonal antibody treatment.
  • Were thrilled to advance science to benefit both existing and future generations of elephants and mammoths, said Justin Quinn, Colossal Director of Product Development.